Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Chubb: Cyber Claim Severity Nearly Doubled for Large Businesses 
Meta Loses Insurance for Defense in Major Social Media Addiction Litigation 
Sources: US Treasury to Consult With Insurance Regulators on Private Credit Lenders 
After 62 Years, Florida Appeals Court Drops the Expert Witness Rule on Attorney Fees 
